Effectiveness of Infiltrations in the Treatment of Plantar Fasciopathy

Launched by UNIVERSITY OF SEVILLE · Oct 31, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating the effectiveness of a treatment called corticosteroid infiltrations for people suffering from plantar fasciopathy, which is a painful condition affecting the bottom of the foot. This condition often makes it difficult for active individuals to walk or engage in physical activities. Participants in the study will be randomly placed into two groups: one will receive the corticosteroid treatment, while the other will receive standard care without injections. The injections will be carefully guided using ultrasound to ensure they are accurate. The trial aims to see if the infiltrations significantly reduce pain and improve foot function over a six-month period compared to the non-invasive treatment.

To be eligible for this study, participants need to be between 18 and 50 years old and have a confirmed diagnosis of plantar fasciopathy. They should have been experiencing pain for at least six weeks, with a pain level of 4 or higher on a scale from 0 to 10. It's important that participants can follow the study guidelines and attend follow-up appointments. However, people with other significant foot issues, those who are pregnant or breastfeeding, or those with certain health conditions will not be able to participate. This study will help provide valuable information for doctors and patients about the best treatment options for plantar fasciopathy.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age: Participants aged 18 to 50 years. Diagnosis: Confirmed diagnosis of plantar fasciopathy based on clinical evaluation and imaging (if applicable).
• • Duration of Symptoms: Symptoms persisting for at least 6 weeks prior to enrollment.
• • Pain Level: Reported pain level of at least 4 on the Visual Analog Scale (VAS) at baseline.
• • Ability to Comply: Participants must be able to follow study protocols and attend follow-up appointments.
• • Informed Consent: Participants must provide written informed consent to participate in the study.
• Exclusion Criteria:
• • Other Foot Pathologies: Presence of other significant foot conditions (e.g., fractures, arthritis, tarsal tunnel syndrome) that could interfere with the study results.
• • Pregnancy or Breastfeeding: Pregnant or breastfeeding individuals will be excluded from the study.
• • Neurological Disorders: History of significant neurological disorders affecting lower limb function.
• • Systemic Conditions: Patients with systemic conditions (e.g., diabetes, autoimmune diseases) that could affect healing or response to treatment.
• • Allergy to Corticosteroids: Known allergy or adverse reaction to corticosteroids or local anesthetics.
• • Psychiatric Disorders: Individuals with severe psychiatric disorders that may impair their ability to provide informed consent or adhere to the study protocol.